Brought to you by:
Paper

Estimation and validation of patient-specific liver elasticity distributions derived from 4DMR for radiotherapy purposes

, , , , , and

Published 10 July 2018 © 2018 IOP Publishing Ltd
, , Citation Katelyn Hasse et al 2018 Biomed. Phys. Eng. Express 4 045038 DOI 10.1088/2057-1976/aace4d

2057-1976/4/4/045038

Abstract

Liver diseases, such as liver cancer and cirrhosis, are commonly associated with changes in the biomechanical properties of liver tissue. Functional imaging techniques such as elastography have shown great promise in measuring the biomechanical properties of liver tissue; however, current liver elastography techniques require additional equipment that is conventionally not available within the radiotherapy setup. We present a novel methodology for estimating liver elasticity derived from deformation observed during 0.35 T 4DMR ViewRay (MRIdian System™, ViewRay™, Cleveland, OH, USA) scans within a radiotherapy setup. Phase 1 and phase 8 datasets, categorized by diaphragm position, were first deformably registered. The resulting displacement maps were considered ground-truth. A GPU-based biomechanical model was then assembled from the segmented phase 8 liver dataset and, along with patient-specific boundary constraints, used to iteratively solve for the liver elasticity distribution. The liver elastography process presented here was performed for a set of 11 4DMR patients. Maximum liver deformation was observed to be between 3.99 and 9.04 mm. On average, 95% convergence within 1 mm was observed. A validation study using phase 4 liver datasets illustrated an accuracy of 86%. Normalized cross-correlation quantified high similarity between the results of the estimation and validation studies with their respective ground-truths. Overall, the results suggest that liver elasticity can be measured with approximately 95% convergence using 4DMR scans acquired within the radiotherapy workflow, indicating the potential for the implementation of liver elastography within the clinic.

Export citation and abstract BibTeX RIS

1. Introduction

Hepatocellular carcinoma (HCC) is one of the most common malignancies, and the third most common cause of cancer-related death worldwide (Jung et al 2013, Jun et al 2017). Surgical resection and liver transplantation are the primary treatment methodologies, however strict criteria limit the pool of eligible patients for both cases. HCC has a poor prognoses, with a 5-year survival rate of less than 12% due to a combination of late diagnosis and lack of efficient therapies for advanced stages (Affo et al 2017). Stereotactic body radiotherapy (SBRT) has been used to treat patients with HCC who are not eligible for other treatments (Feng et al 2017). SBRT uses advances in imaging and conformal radiotherapy to deliver ablative, high dose radiation in order to optimize local control. Radiation-induced liver disease (RILD) is a significant limiting factor in the use of SBRT because there are no effective treatments or predictors (Jung et al 2013). Most patients with HCC have pre-existing cirrhosis or hepatitis, which increases their risk of RILD (Kim et al 2015). Baseline liver function is thought to be the most important factor associated with risk of RILD (Jun et al 2017). Pre-treatment visualization of liver function in vivo is necessary in order to expand the use of SBRT for HCC.

The liver plays a role in metabolism, synthesis, secretion, immunity, and many other functions (Luna et al 2014). Liver disease, including cirrhosis, fibrosis and tumors, can disrupt the functions of the liver by altering the biomechanical properties of the tissue, most notably by changing the tissue stiffness (Sandrasegaran 2014, Li et al 2015). Clinically, elastography provides a measurement of liver stiffness and is a predictor for HCC (Pepin et al 2014). Magnetic resonance elastography (MRE) can noninvasively and quantitatively assess the elasticity characteristics of soft tissue (Li et al 2015). Liver stiffness measured by MRE has been shown to correlate well with histologic staging of fibrosis and differentiation of benign and malignant liver lesions (Venkatesh et al 2015). However, current MRE techniques require equipment that is not typically available within a radiotherapy setup.

Recently, an MR guided radiation therapy (MRgRT) system (MRIdian System™, ViewRay™, Cleveland, OH, USA) was introduced in the field of radiotherapy (RT) (Mutic and Dempsey 2014). The ViewRay system integrates a 0.35 T MRI with three Cobalt-60 sources, which allows for simultaneous MRI acquisition and treatment delivery for a variety of malignancies (Wojcieszynski et al 2016). The superior soft tissue contrast from Viewray's on-board MRI enables soft tissue based gated RT and on-line adaptive RT. Both techniques are especially helpful for treating thoracic and abdominal tumors by accounting for intra-fractional and inter-fractional motion. In this study, we present a novel elastography process for estimating liver tissue elasticity using 0.35 T 4DMRI to observe liver deformation in each respiratory cycle during patient simulation. The rest of this paper is organized as follows: section 2 introduces the methods employed for the deformable imaging registration, elasticity estimation, validation, and quantitative evaluation. Section 3 presents the qualitative and quantitative results of the deformable image registration, elastography, and validation processes. Section 4 presents a discussion of the results and highlights the areas for continued research, while section 5 concludes the paper.

2. Methods

Our elastography process focuses on estimating the effective Young's modulus for each voxel of liver tissue using 4DMR liver data. Figure 1 shows a flow chart summarizing the elasticity estimation. First, phase 1 and phase 8 datasets from the 4DMR liver images were registered using an optical flow deformable image registration (DIR) algorithm (Min et al 2014). Liver deformation vectors (DVFs) were obtained for every voxel of liver tissue. The biomechanical model was then assembled using segmented phase 1 liver geometry and a randomly initialized elasticity distribution. Using the ground-truth liver DVFs, the elasticity distribution was optimized. The inverse elasticity problem was formulated as a parameter-optimization problem with an objective to determine the elasticity parameter that would minimize the difference between the ground-truth deformation and the deformation computed by a biomechanical model. The biomechanical model and inverse elasticity estimation was implemented on a GPU cluster, which allowed the elasticity estimation for each patient dataset to converge in around 2 h. Spatial elasticity and displacement error distributions were then obtained and validated.

Figure 1.

Figure 1. Flow chart describing the liver elastography process. Two 4DMR liver phases are registered and ground-truth deformation vectors are obtained. A biomechanical model is used to obtain an optimal elasticity estimation and error analysis.

Standard image High-resolution image

In this section, we first briefly present the 4DMR acquisition process and the DIR technique used to obtain the ground-truth DVF. Next, we present the constitutive model and convergence criteria used for the elasticity estimation process. We then describe a technique that was used to validate the estimated elasticity. We conclude the section with a discussion of the metrics used to evaluate the quantitative accuracy of the elasticity estimation and validation results.

2.1. 4DMRI acquisition

The study was approved by our institutional review board and each patient provided written informed consent. Eleven patients with tumors in the liver treated on Viewray were included in our study. The MRI study was performed immediately after high resolution 3D MRI simulation acquisition. The 4DMRI sequence parameters are: TE/TR = 3.0/6.0 ms; bandwidth = 400 Hz/pixel; FA = 110°; field-of-view = 500 × 350 × 200 mm, resolution = 1.3 × 1.3 × 1.8 mm3, acquisition time = 7 min No specific breathing instruction was given to the subjects during the MRI exam.

2.2. Deformable image registration

The model-guided elasticity approach presented in this paper relies on displacement values extracted from DIR of 4DMR datasets. 4DMR datasets were acquired from 4DMR ViewRay (MRIdian System™, ViewRay™, Cleveland, OH, USA) scans taken within a radiotherapy setup. The 4DMR datasets were separated into phases according to diaphragm position. The liver was manually segmented and phase 1 datasets, corresponding to end inspiration, and phase 8 datasets, corresponding to end expiration, were then deformably registered using a well-validated in-house multi-level optical flow DIR algorithm (Min et al 2014). The resulting DVFs were taken to be the ground-truth displacement for the elasticity estimation process. For the rest of the paper, the phase 8 datasets will be considered the source images, the phase 1 datasets will be considered target images, and the phase 8 datasets deformed according the ground-truth DVFs will be considered warped images.

2.3. Elasticity estimation

The inverse elasticity problem was formulated as a parameter-optimization problem with an objective to determine the elasticity parameter that would minimize the difference between ground-truth DVFs and those computed by a constitutive biomechanical model. Solving the inverse elasticity problem was carried out in two steps: (1) estimating the DVF for every voxel of liver tissue for a given elasticity distribution and boundary constraint using the biomechanical model, and (2) optimizing the elasticity distribution to best reproduce the ground-truth DVF. These steps will be further explained in the following sections.

2.3.1. Biomechanical model

The first step requires a forward biomechanical constitutive model. The model presented in this section is focused on computing the liver tissue deformation for a give boundary constraint arising from the ground-truth DVF. This model has been previously described for the head and neck, breast, and lung anatomies in (Neylon et al 2015, Hasse et al 2016, Hasse et al 2017a, Hasse et al 2017b) but will be summarized briefly here. This approach is appropriate for our current study since its applicability has been systematically investigated for breathing motion, which is the main factor in diaphragm-induced liver deformations (Wu et al 2008).

The biomechanical liver model was assembled from the segmented 4DMR phase 8 dataset. The model geometry was represented by finite element nodes corresponding to the center of each voxel of the phase 8 image. Liver tissue was viewed as a series of finite mass elements coupled with linear elastic connections to adjacent mass elements in deformation space to ensure a physically realistic deformation. Our approach uses linear elastic constitutive laws that were implemented because of the quasi-static tissue response of liver tissue to small diaphragm-induced deformations (Nava et al 2008).

The model is actuated by enacting changes in boundary constraints, which causes corrective forces to be applied to each mass element. The boundary constraints were computed from the liver boundary DVF. The corresponding corrective forces on each mass element were calculated by summing elastic, shear, and dashpot damping forces for each connected elements. The elastic force $({\overrightarrow{f}}_{E,ab})$ acting between two mass elements a and b is described by:

Equation (1)

where Eab is the effective Young's modulus acting between the two elements a and b, and Lab is the rest length distance, and ΔLab is the change in length between the two elements. Since liver tissue is modeled as a linearly elastic material, (1) is derived from the inverse relationship between Young's modulus and displacement; for a constant force, if elastic modulus increases then displacement must decrease and vice versa (Doyley et al 2000).

The shear spring force $({\overrightarrow{f}}_{S,ab})$ on element a due to element b is described by

Equation (2)

where Sab is the shear moduli between elements a and b, set to 4 kPa for each voxel in our estimations, an approximation based on the relationship between shear modulus, Young's modulus, and Poisson's ratio and similar to values seen in (Liu et al 2010, Suki et al 2011). The dashpot damping force is calculated from the relative velocities $\overrightarrow{v}$ of elements a and b, and a local damping factor μab

Equation (3)

The new positions and velocities of each mass element $({\overrightarrow{x}}_{a}^{n+1},{\overrightarrow{v}}_{a}^{n+1})$ were then updated from the previous values $({\overrightarrow{x}}_{a}^{n},{\overrightarrow{v}}_{a}^{n})$ using Implicit Euler integration and the total internal corrective force $\overrightarrow{{f}_{a}}.$

Equation (4)

Equation (5)

In (4) and (5), δ is the time step between iterations, ma is the mass of each mass element a, and $\overrightarrow{g}$ is the acceleration due to gravity. The distance between the new and previous positions of each mass element was taken to be the displacement for that mass element, henceforth denoted as da.

2.3.2. Optimization process

The iterative scheme for estimating the elasticity distribution is based on the inverse relationship between Young's modulus and displacement. Given an initial elasticity distribution, the constitutive model described above computed the displacement of every mass element. These displacements were compared with the ground-truth DVF values, and the elasticity distribution was updated until the differences was minimal. New displacements were generated for each iteration by updating the effective elasticity distribution as described below.

Initial (Ea), minimum (Emin,a), and maximum (Emax,a) Young's modulus values were initialized for each voxel a in the biomechanical model. For liver elastography purposes, the Young's modulus range was set to be from 1 kPa to 25 kPa, an extended approximation of values from the literature (Nitta et al 2009). The displacement differential was calculated according to the following relationship:

Equation (6)

where d0,a and da refer to the ground-truth and model generated displacements of voxel a, respectively. The displacement differential was then used to binaurally update the Emin,a and Emax,a:

Equation (7)

Equation (8)

A new Ea', which became the initial value for the next iteration, was then generated at each iteration according to the modified Gauss-Newton optimization scheme (Fu et al 2000) with a step size:

Equation (9)

giving us:

Equation (10)

After the elasticity was updated, the biomechanical model was then reset to the initial un-deformed rest position, and the boundary constraints were re-applied. The reconstruction process was repeated until a suitable stopping (convergence) criteria was reached.

2.4. Quantitative evaluation and validation

The convergence metrics utilized in this study are critical to interpreting the results. At each iteration of the elasticity estimation, the resultant model DVF was compared to the ground-truth DVF. The number of voxels that converged with a certain tolerance epsilon was quantified as follows:

Equation (11)

Equation (12)

In (11), epsilon represents the L2-norm of the DVF for each voxel a and ca represents the error for each voxel. The percent accuracy, ${p}_{{\epsilon }}$ was then tabulated by summing the ca over all voxels. For elastography purposes, the iterative process was stopped when ${p}_{{\epsilon }}\geqslant 0.95$ or after 100 iterations. The convergence criteria was formulated to be 1 mm, the current standard for DIR-based targeting errors for liver SBRT dose planning purposes (Velec et al 2011).

An additional error metric was necessary in order to ensure the precision of the estimated elasticity. Specifically, we needed to ensure that the estimated elasticity and displacement distributions could be used to warp the phase 1 liver dataset to closely represent the phase 8 image. Furthermore, the accuracy of the ground-truth data needed to be more fully quantified. For this purpose, normalized cross-correlation was used as an imaging metric to quantify accuracy between both the target and warped images along with the model-deformed and ground-truth deformed images. Normalized cross-correlation was used because it has been found to be an accurate similarity measurement for the registration of soft tissue, and is unaffected by intensity changes (Penney et al 1998).

A key part of our focus is to validate the estimated elasticity using clinical datasets. However, patient-specific elasticity distributions have not been previously documented in the literature. For validation purposes, deformation vectors from the phase 4 datasets (representing mid-expiration breathing phase) that were not used for the elasticity estimation were employed. The accuracy of the elasticity distribution derived from phase 1 and phase 8 datasets was quantified by its' ability to also represent the phase 4 liver data. To further ensure the quantitatively evaluate the precision of the DIR and the estimated elasticity, normalized cross-correlation (NCC) was used as an image similarity metric between two sets of images for both the estimation and validation process: first between the target and warp images used in the deformable image registration, and second between the target image and model-deformed images.

3. Results

In this section, we first present the qualitative DIR results, followed by qualitative elasticity estimation and validation results. Finally, we present the quantitative results for the respective sections.

3.1. Deformable image registration

The accuracy of the DIR results is necessary to ensure the validity of the ground-truth deformation data. Figure 2 illustrates an example of the DIR for a 2D-slice of 4DMR data. Figure 2(a) shows the source data (phase 8 dataset) in red overlain with the target (phase 1) data in green. Mismatches can be seen between the source and target, especially near the diaphragm and liver boundaries. Figure 2(b) shows the target data is red overlain with the warped source data in green. It can be seen that the registration accounts for the liver deformation well, with little mismatch seen between the target and warp images. The extent of the registration accuracy will be further quantified in section 3.3.

Figure 2.

Figure 2. Example of the registration results achieved with our in-house optical flow algorithm. The source (red) and target (green) (a) were registered, resulting in the warped (green) image that is overlain with the target in (b).

Standard image High-resolution image

3.2. Elasticity estimation.

Figure 3 shows the displacement accuracy corresponding with a resultant elasticity map for a 2D-slice of patient liver. Figure 3(a) shows the source image of a segmented liver. Figure 3(b) shows the ground-truth displacement derived from DIR in mm, while figure 3(c) shows the optimized model displacement, also in mm. Figure 3(d) shows the displacement error between 3(b) and 3(c), with error greater than 1 mm highlighted in blue. Finally, figure 3(e) shows the optimized elasticity distribution. The low error supports the validity of the error estimation. Furthermore, regions of high elasticity correspond to apparent liver lesions seen in figure 3(a).

Figure 3.

Figure 3. Example of elasticity estimation results. (a) source, (b) ground-truth displacement in mm, (c) model displacement in mm, (d) displacement error in mm, and (e) estimated elasticity in kPa.

Standard image High-resolution image

3.3. Quantitative evaluation and validation

Table 1 indicates the average elasticity, displacement, and accuracy for both the estimation and validation for each patient dataset. Overall, 95% of voxels converged within 1 mm of ground-truth. The average elasticity ranged from 2.69 kPa to 6.42 kPa. The maximum deformation ranged from 3.73 mm to 9.04 mm. Variations in the liver physiological factors, such as range of motion, did not affect the accuracy, indicating the applicability of the elastography process to a wide range of patients.

Table 1.  Elasticity estimation and validation results for 11 patient datasets.

  Estimation Validation
Patient Elasticity (kPa) Maximum displacement (mm) Error < 1 mm Maximum displacement (mm) Error < 1 mm (%)
1 5.88 9.04 71.34 7.88 53.10
2 2.69 5.10 98.88 5.08 97.94
3 5.91 4.96 97.61 3.05 86.94
4 6.16 6.29 94.64 3.76 91.42
5 4.90 6.30 98.97 5.83 85.61
6 6.26 8.60 99.13 6.56 88.22
7 6.42 6.61 96.17 5.71 95.07
8 5.80 7.64 96.35 5.73 69.92
9 4.44 3.73 100 2.79 100
10 5.28 3.99 99.98 2.59 99.584
11 5.06 6.34 96.61 6.20 76.67
AVG 5.34 6.23 95.43 5.02 85.86

As no ground-truth elasticity distributions are available for absolute elasticity accuracy calculations, validation was performed using phase 4 (representing mid-expiration breathing phase) 4DMR liver data. To illustrate the validation process and results, we present figure 4. Figure 4(a) shows the elasticity estimated from the ground-truth displacement vectors. Figure 4(b) shows the validation displacement acquired from deformable image registration between phase 1 and phase 4 images. Figure 4(c) shows the resultant model displacement in mm after the liver biomechanical model is deformed with the elasticity seen in figure 4(a). Figure 4(d) shows the displacement error between (b) and (c), with error greater than 0.3 mm highlighted in blue. A majority of the voxels converged with high accuracy, illustrating the estimated elasticity's validity in representing different 4DMR phases. The validation results are quantitated in table 1; maximum deformation ranges from 2.59 to 7.88 mm, and average accuracy is 86%.

Figure 4.

Figure 4. Example of validation results. (a) estimated elasticity, (b) validation displacement, (c) model displacement using estimated elasticity for a scaled number of iterations, and (d) displacement with error greater than 0.3 mm highlighted in blue.

Standard image High-resolution image

Finally, image similarity results are presented in table 2 below. On average, the deformable image registration had an accuracy of around 0.97 for both the estimation and validation processes. The resultant model-deformation represented the ground-truth deformation with a similarity of 0.97 for the estimation process and 0.90 for the validation process.

Table 2.  Image similarity metric normalized cross-correlation between target (phase 1) and warp (deformed phase 8) data and optimized model deformation and ground-truth deformation for both estimation and validation results.

  Estimation Validation
  Target → Warp Model DVF → Ground-truth DVF Target → Warp Model DVF → Ground-truth DVF
1 0.941 0.978 0.952 0.866
2 0.966 0.861 0.967 0.779
3 0.982 0.972 0.977 0.931
4 0.979 0.944 0.977 0.795
5 0.974 0.993 0.973 0.947
6 0.972 0.982 0.977 0.949
7 0.974 0.953 0.972 0.896
8 0.973 0.994 0.984 0.912
9 0.963 0.993 0.965 0.952
10 0.954 0.995 0.961 0.916
11 0.966 0.990 0.973 0.971
Average 0.968 0.969 0.971 0.901

4. Discussion

In this paper, we presented the results of a liver elastography process performed on 11 4DMR datasets. A physics-based biomechanical model was used to solve the inverse elasticity problem. Liver DVFs from the registration of phase 1 and phase 8 diaphragm positions were obtained using an in-house optical flow DIR algorithm. Liver boundary displacements were employed as boundary constraints, while the inner liver tissue voxels were allowed to deform according to linear elastic material properties.

On average, 95% of voxels for 11 patients converged within 1.0 mm of ground-truth deformation. Maximum deformation ranged from 3.73 to 9.04 mm for the estimation cohort. The average elasticity ranged from 2.69 to 6.42 kPa. The average values found here correspond well with those found in the current work in the field (Singh et al 2015, Venkatesh et al 2015, Zeng et al 2017). In addition, an image similarity metric showed high similarity between the phase 8 and warped phase 1 registration and experimental results, with values of 0.97 and 0.97 respectively. Overall, these results suggest that liver elastography can be performed using ViewRay 4DMR datasets for a wide range of patients.

The potential of 4DMR liver elastography to be used in the clinic requires extensive validation. Phase 4 datasets were obtained as a validation cohort so that the elasticity results could be validated in a clinically-relevant manner. The maximum deformation ranged from 2.59 to 7.88 mm for the validation cohort, and 86% of voxels converging within 1 mm of clinical ground-truth deformation. An image similarity metric again showed high similarity between phase 4 and warped phase 1 registration and validation model results, with values of 0.97 and 0.90 respectively. Future work will investigate obtaining MRE data for patients so the elasticity distributions can be more explicitly and quantitatively validated.

We foresee two main limitations to the methodology presented here. First, the linear elastic constitutive model employed in the biomechanical model might be overly simplistic for describing the diaphragm-induced motion of diseased liver tissue. Future studies will focus on expanding to a non-linear constitutive model. Secondly, since the ViewRay implementation at UCLA is relatively new, we only had access to a small number of patients. Future work will focus on collecting more patients for further studying the elastography process along with a multi-modal validation.

5. Conclusion

The 95% convergence of the elastography technique presented here indicates the potential for integrating liver elastography directly within the radiotherapy workflow. Elastography of the liver anatomy using (Viewray) 0.35 T MR Scanners has not yet been developed and validated. The elastography process described in this manuscript can be implemented within the radiotherapy treatment setup without the need for additional imaging modalities. Elastography information acquired within the radiotherapy setup can lead to improved tissue sparing radiotherapy treatment plans and more precise monitoring of treatment response.

Acknowledgments

This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. DGE-1144087, the US Department of Defense Virtual Tissue Consortium, and the UCLA Department of Radiation Oncology.

Please wait… references are loading.
10.1088/2057-1976/aace4d